Based on these data, MKRN1 deficiency promotes hepatic AMPK activation, possibly resulting in reduced hepatic lipid accumulation and the prevention of NAFLD. This evidence concerns the gene MKRN1 and metabolic dysfunction-associated steatotic liver disease.